Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Adenylosuccinate lyase as an indicator of breast and prostate malignancies: a preliminary report.

Authors: Reed, VL  Mack, DO  Smith, LD 
Citation: Reed VL, etal., Clin Biochem. 1987 Oct;20(5):349-51.
Pubmed: (View Article at PubMed) PMID:3690833

The high activity of adenylosuccinate (SAMP) lyase found in rat breast tumor, and its relative absence from normal rat breast tissue, suggests that it may serve as an indicator for human breast malignancy. Its activity has been measured in human breast tumors, both malignant and benign. The two were clearly separated with no overlap in activity between the malignant and benign tissues. Human prostate tissues were also examined for SAMP lyase. A cut-off level of 5 U/mL gave a false-positive rate of 11% with no false negatives. These results indicate that further work is warranted to determine the effectiveness of SAMP lyase as an indicator of breast and prostatic cancers.

Annotation

Disease Annotations
Objects Annotated
Objects referenced in this article

Additional Information

 
RGD Object Information
RGD ID: 1598760
Created: 2006-12-18
Species: All species
Last Modified: 2006-12-18
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.